Discovery of novel 1,3,5‐triazine as adenosine A<sub>2A</sub> receptor antagonist for benefit in Parkinson's disease.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2021, v. 35, n. 3, p. 1, doi. 10.1002/jbt.22659
- By:
- Publication type:
- Article